KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its existing shareholders and Silicon Valley Bank (SVB), the bank of the world's most innovative companies and their investors.